
NDRF to soon commission cadaver dogs to assist in disaster operations
National Disaster Response Force
(NDRF) will soon operationalise its first contingent of cadaver dogs who can sniff out the dead or human remains in a disaster or accident zone, officials in the federal organisation said.
About half-a-dozen such dogs are under training at the NDRF battalion bases in Arakkonam in Tamil Nadu and Uttar Pradesh's Ghaziabad for the last few months, they said.
Explore courses from Top Institutes in
Select a Course Category
Healthcare
Technology
PGDM
healthcare
Digital Marketing
Data Analytics
MCA
Operations Management
Project Management
Design Thinking
CXO
Data Science
Cybersecurity
Finance
Public Policy
others
Product Management
Others
Artificial Intelligence
Management
Degree
Data Science
Leadership
MBA
Skills you'll gain:
Financial Analysis in Healthcare
Financial Management & Investing
Strategic Management in Healthcare
Process Design & Analysis
Duration:
12 Weeks
Indian School of Business
Certificate Program in Healthcare Management
Starts on
Jun 13, 2024
Get Details
For training the special canines, largely from the
Belgian Malinois
and Labrador breed, the force has procured a special scent from abroad that smells akin to the odour emitted by a dead body, they said.
"For all these years, the NDRF focussed on its mandate of saving lives. Utilising the golden hour of finding life during a disaster has been the guiding principle of the rescuers and hence finding the dead or mortal remains was not a priority," a senior NDRF officer explained to PTI.
However, we have seen that the force is also part of operations where NDRF personnel are tasked to retrieve bodies from under the debris like in the aftermath of a landslide or train or road accident, he said.
Live Events
Finding bodies or human remains is important to ensure closure to the families and near and dear ones of the victims, he said.
Hence, the NDRF few months back embarked on a maiden exercise to train cadaver dogs, the officer said.
A second officer said there are hardly any such dogs in the establishment of state rescue forces in India and those who have them, have had a mixed success rate.
The success of such dogs depends on a lot of factors, including prevailing weather conditions, humidity, snow and presence of other strong odours in the area of operation. Detection of the dead is harder than the alive, he said.
"Training such dogs is a challenge as it required a human body or body parts which is not easily available. Hence, a special scent that smells like dead human remains was procured for training the NDRF dogs," the second officer said.
The dogs are expected to complete their training by the next month and then they will be placed with some specific NDRF battalions out of the total 16 spread across the country, he said.
This was one important canine tool missing in our arsenal. Once deployed, we will get to know about the success rate of such dogs, the first officer said.
Two such dogs of the Kerala Police were deployed early this year during the Srisailam Left Bank Canal (SLBC) tunnel collapse in Telangana where eight persons were trapped. These dogs were also used during the Wayanad landslides that took place in 2024.
The force was raised in 2006 and at present has a strength of about 18,000 men and women rescuers deployed across the country as part of 16 battalions and over 30 regional response centres.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
37 minutes ago
- Time of India
NephroPlus files DRHP with Sebi, to raise Rs 353 crore via fresh issue
Dialysis services provider Nephrocare Health Services Limited has filed the draft red herring prospectus ( DRHP ) with capital markets regulator Securities and Exchange Board of India ( Sebi ) to raise funds through an initial public offering (IPO). The company plans to raise Rs 353.4 crore via issue of fresh shares. According to the DRHP, the proposed IPO of the Hyderabad-based company is a combination of a fresh issue of equity shares and an offer for sale (OFS) of up to 1.27 crore equity shares by the selling shareholders. Explore courses from Top Institutes in Please select course: Select a Course Category Product Management Finance Others Data Science CXO Degree others Leadership Technology Artificial Intelligence MBA Digital Marketing Public Policy Operations Management Data Science Cybersecurity PGDM MCA Project Management Management Healthcare Design Thinking healthcare Data Analytics Skills you'll gain: Product Strategy & Competitive Advantage Tactics Product Development Processes & Market Orientations Product Analytics & Data-Driven Decision Making Agile Development, Design Thinking, & Product Leadership Duration: 40 Weeks IIM Kozhikode Professional Certificate in Product Management Starts on Jun 26, 2024 Get Details Skills you'll gain: Creating Effective Product Roadmap User Research & Translating it to Product Design Key Metrics via Product Analytics Hand-On Projects Using Cutting Edge Tools Duration: 12 Weeks Indian School of Business ISB Product Management Starts on May 14, 2024 Get Details Skills you'll gain: Product Strategy & Roadmapping User-Centric Product Design Agile Product Development Market Analysis & Product Launch Duration: 24 Weeks Indian School of Business Professional Certificate in Product Management Starts on Jun 26, 2024 Get Details by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Swelling and internal bleeding in the brain, help this baby Donate For Health Donate Now Undo As part of the OFS, the promoter selling shareholders include Investcorp Private Equity Fund II, Healthcare Parent Limited, Investcorp Growth Opportunity Fund and Edoras Investment Holdings Pte. Ltd. and Other Selling Shareholders include Investcorp India Private Equity Opportunity Limited, International Finance Corporation, 360 One Special Opportunities Fund - Series 9 and 360 One Special Opportunities Fund - Series 10. The company is in consultation with the Book Running Lead Managers (BRLMs) and may consider a pre-IPO Placement aggregating up to Rs 70.6 crore prior to filing of the Red Herring Prospectus (RHP) with the ROC. If the pre- IPO placement is undertaken, then the fresh issue will be reduced to the extent of such pre-IPO placement. About Nephrocare Health Services Live Events Known for its brand NephroPlus, the company claims to be Asia's largest dialysis services provider and fifth largest globally in terms of number of treatments performed in Fiscal 2025, citing F&S report. Incorporated in 2009, NephroPlus has 447 clinics across 269 cities in 21 states and 4 Union Territories. It serves more than 33,000 patients globally on an annual basis and has a revenue market share of over 50% in India's organised market (in terms of number of treatments), the draft filing said. It has also expanded its international footprint to include Philippines (34 clinics), Uzbekistan (4 clinics), Nepal (5 clinics) and has entered the Middle East market through the Kingdom of Saudi Arabia recently. Vikram Vuppala, BVP (Bessemer Venture Partners) Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited (HPL), Investcorp Private Equity Fund II (IPEF II) and Investcorp Growth Opportunity Fund (IGOF) are the promoters of the company. Nephrocare Health Services proceeds utilisation NephroPlus has proposed to utilise the net proceeds of the fresh issue towards capital expenditure to the tune of Rs 129.1 crore for opening new dialysis clinics in India. It will use Rs 136 crore for pre-payment or scheduled repayment of certain borrowings availed by the company and rest on general corporate purposes. In FY25, NephroPlus reported revenue from operations of Rs. 755.8 crore and profit after tax of Rs. 67 crore. Currently, kidney disease is the third fastest-growing cause of death globally and diabetes and hypertension have been recognized as the two leading drivers of chronic kidney disease (CKD). Rapid urbanization and lifestyle changes have further contributed to the increased incidence of CKD. ICICI Securities Limited, Ambit Private Limited, IIFL Capital Services Limited and Nomura Financial Advisory and Securities (India) Private Limited are the Book Running Lead Managers to the issue. ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)


Time of India
2 hours ago
- Time of India
He's not a traffic cop, yet this 72-year-old from Delhi has been managing traffic for past 32 years without pay. Who is Gangaram?
Some individuals dedicate their entire existence to noble causes, driven not by recognition or rewards, but by the deep desire to bring positive change to the world around them. Their contentment lies in knowing their efforts might prevent pain for others. In a bustling corner of Delhi, one such man quietly carries out his mission. Seventy-two-year-old Gangaram has been regulating traffic at the chaotic Seelampur junction for over three decades, all without expecting a salary. He isn't part of the traffic police, nor has he been officially appointed by any authority. Yet, every single day, clad in a uniform and wielding a baton, he spends over 10 hours managing the flow of vehicles with utmost dedication. His decision to take on this role was born from personal tragedy. Years ago, Gangaram's son was killed in a road mishap at the same Seelampur signal where he now works. The two used to run a modest TV and electronics repair shop in the neighborhood. After losing his only child and, shortly thereafter, his wife—who couldn't bear the emotional weight of the loss—Gangaram found himself utterly alone. Grief-stricken but resolute, he turned his sorrow into a mission: to prevent such accidents from claiming more lives. Explore courses from Top Institutes in Please select course: Select a Course Category Healthcare Operations Management Product Management healthcare Degree Artificial Intelligence Finance Digital Marketing Management Design Thinking Data Science Others Leadership Technology Cybersecurity CXO Public Policy PGDM MCA others MBA Data Analytics Data Science Project Management Skills you'll gain: Financial Analysis in Healthcare Financial Management & Investing Strategic Management in Healthcare Process Design & Analysis Duration: 12 Weeks Indian School of Business Certificate Program in Healthcare Management Starts on Jun 13, 2024 Get Details Even during the peak of the COVID-19 pandemic, when elderly citizens were urged to remain indoors for their safety, Gangaram never stayed home. His unwavering commitment to managing traffic continued, despite the risks. Rain, heat, or lockdown—nothing could deter him. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Top 15 Most Beautiful Women in the World Undo Recently, his story caught the internet's attention when the widely followed platform Instant Bollywood shared his journey. The post quickly went viral, garnering over 16,000 likes and heartfelt reactions. Social media users flooded the comment section with admiration, calling for national recognition of his service and praising his courage and sense of responsibility. Gangaram remains a poignant reminder of how one man's grief can be transformed into a lifelong mission to protect others—an everyday hero guarding Delhi's roads, asking for nothing in return.


Time of India
8 hours ago
- Time of India
The estrogen nobody told you about is changing hormone care — here's why it matters now
Estrogen hormone therapy with estetrol E4: Estrogen treatments have depended on three core types: estrone, estradiol, and estriol for decades, but new on the horizon is a lesser-known natural estrogen called estetrol, or E4, that is slowly altering the process of hormone treatment, as per a report. Made by the fetal liver only during pregnancy, E4 differs from its more famous hormonal cousins and has promising advantages that may revolutionize how women treat hormone therapy, according to a Flow Space report. A New Era in Estrogen Therapy: Meet Estetrol E4 Unlike other estrogens, E4 acts selectively on some of the body's tissues, as per the report. Nurse practitioner Alexandra Rooker of The Lanby, a functional medicine clinic, explains that E4 selectively activates estrogen receptors in a way that may provide therapeutic benefits while minimizing stimulation of tissues like the breast and liver,' as quoted by Flow Space. This selectivity is what makes E4 potentially deliver many of the benefits of estrogen therapy, such as alleviating menopausal symptoms, without some of the dangers associated with older hormone therapies. Explore courses from Top Institutes in Please select course: Select a Course Category CXO PGDM Design Thinking Finance healthcare Operations Management Public Policy Degree others Data Analytics Data Science Digital Marketing Artificial Intelligence Healthcare Management Cybersecurity Leadership Technology Product Management Data Science Others MBA MCA Project Management Skills you'll gain: Operations Strategy for Business Excellence Organizational Transformation Corporate Communication & Crisis Management Capstone Project Presentation Duration: 11 Months IIM Lucknow Chief Operations Officer Programme Starts on Jun 30, 2024 Get Details Skills you'll gain: Technology Strategy & Innovation Emerging Technologies & Digital Transformation Leadership in Technology Management Cybersecurity & Risk Management Duration: 24 Weeks Indian School of Business ISB Chief Technology Officer Starts on Jun 28, 2024 Get Details Skills you'll gain: Customer-Centricity & Brand Strategy Product Marketing, Distribution, & Analytics Digital Strategies & Innovation Skills Leadership Insights & AI Integration Expertise Duration: 10 Months IIM Kozhikode IIMK Chief Marketing and Growth Officer Starts on Apr 7, 2024 Get Details Skills you'll gain: Digital Strategy Development Expertise Emerging Technologies & Digital Trends Data-driven Decision Making Leadership in the Digital Age Duration: 40 Weeks Indian School of Business ISB Chief Digital Officer Starts on Jun 30, 2024 Get Details ALSO READ: Happy Gilmore 2 brings Adam Sandler's family back to the screen! What roles do his daughters Sadie and Sunny play in the Netflix film? by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like This Could Be the Best Time to Trade Gold in 5 Years IC Markets Learn More Undo Why Selective Activity Matters in Hormone Therapy Researchers are calling E4 a "Native Estrogen with Selective Tissue activity," or NEST, since it's specifically where it's needed and not overstimulating in sensitive areas, as per the Flow Space report. That specificity may render E4 a safer option for hormone replacement therapy (HRT) and birth control , particularly for women concerned about side effects such as blood clots or breast tissue stimulation, as per the report. What Makes Estetrol E4 So Different? What sets E4 apart is its source: it's made naturally during pregnancy and disappears at birth. For decades, it was a biological oddity rather than a useful drug. But new research has found that E4 acts differently than other estrogens. It selectively hits useful tissues such as bones and vaginal lining, while having less impact on the liver and breast tissue, tissues where too much estrogen activity can lead to trouble, according to Flow Space. Live Events E4 Is Already in Some Birth Control Pills E4 is already incorporated in some oral contraceptives, including Nextstellis, wherein it prevents pregnancy but with fewer effects on blood clotting and liver function than usual estrogens, as per the report. Researchers are now exploring E4's ability to alleviate hot flashes and night sweats of menopause while possibly reducing risks linked to older hormone therapies, according to Flow Space. ALSO READ: Donald Trump's Scotland visit: Golfing or diplomacy? The real agenda uncovered! Could E4 Make Hormone Therapy Safer? According to Dr. Neha Pathak, chief physician editor at WebMD, E4 is 'Some forms of broken-down estrogen are thought to be gentler on the body, while others may be more active and possibly linked to health risks like breast cancer,' adding, 'But it's more complex than just good or bad; we still have a lot to learn about what these changes really mean for long-term health,' as quoted by Flow Space. This approach is a huge step forward in itself, since older forms of estrogen can increase risks of strokes, heart problems, and other health concerns, particularly in older women or those with existing conditions, as per the report. Early research indicates E4 has a stable half-life that is adequate for once-daily oral administration and a milder impact on the liver, as per the report. Rooker explained, 'This may translate into a safer alternative for many women, particularly regarding clotting risks and breast tissue stimulation,' as quoted in Flow Space. According to the report, estetrol-based menopause hormone therapy is likely to be on the market as soon as 2026. This new treatment might provide more personalised and safer options for patients and physicians in controlling symptoms, as per Flow Space. Beyond Women's Health: E4 in Cancer and Male Birth Control Aside from menopause and birth control, scientists are also studying E4's use to treat hormone-sensitive cancers , such as some breast and prostate cancers, due to its selectivity, according to the report. E4 is even being looked at as part of a possible male birth control pill because of its balanced hormonal effects and low impact on the liver and blood clotting, two major concerns in developing hormonal contraceptives for men , as reported by Flow Space. FAQs What is estetrol (E4)? Estetrol is a natural estrogen made by the fetal liver during pregnancy. It's now being studied for use in hormone therapy and birth control. Is E4 safer than other types of estrogen? Early research suggests that E4 is gentler on the liver and blood clotting system, which may reduce risks like strokes and breast tissue stimulation.